The Full Federal Court’s docket for 2025 is stacked with class action appeals after a bad run for plaintiffs at trial.
A court has refused to order the applicant in a failed class action against NULIS Nominees to pay indemnity costs, but has confirmed that so-called Calderbank offers can operate in group proceedings.
US drug maker Allergan may defend a class action over recalled textured breast implants by arguing its knowledge of the alleged defects was limited by the state of scientific knowledge at the time the products were made.
Former NAB superannuation fund trustee NULIS is seeking the first ever award of indemnity costs in a class action that flopped following the rejection of a settlement offer.
In the latest class action loss, a judge has said that $165 million in fees charged to members by NAB super fund trustee NULIS Nominees was corporate revenue “with which it was free to deal as it saw fit”.
A class action against NAB unit NULIS Nominees over adviser fees charged to superannuation fund members should be dismissed, a judge has found.
NAB unit NULIS Nominees was not only allowed to charge superannuation fund members fees for adviser commissions, it was “obliged” to do so, a court has heard during a class action trial over alleged conflicted remuneration.
NAB unit NULIS Nominees was “hopelessly conflicted” in continuing to charge allegedly unlawful adviser commissions to superannuation fund members, a court has heard on the first day of a class action trial.
Class action settlement sums reached new highs last year, with the ten largest agreements totalling almost $1 billion, almost half of which was secured by one plaintiff law firm.
Avant Insurance has lost its bid to challenge a ruling which put it on the hook for indemnifying a plastic surgeon in class action proceedings over allegedly botched breast augmentations at a defunct NSW clinic.